Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors Conference
February 27, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Raymond James...
Antares Pharma to Report Fourth Quarter and Full Year 2018 Financial and Operating Results
February 25, 2019 17:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2018 financial results and recent operating...
Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors
December 13, 2018 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Mr. Greenleaf has over...
Antares Pharma Announces the Commercial Availability of XYOSTED™ (Testosterone Enanthate) Injection — A New Treatment for Adult Men Diagnosed With Testosterone Deficiency
November 29, 2018 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. XYOSTED™ is the only FDA approved...
Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen®
November 27, 2018 10:36 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that Teva Pharmaceutical Industries, Ltd.’s (“Teva”) generic EpiPen® is now...
Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 26, 2018 07:30 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the 30th Annual Piper...
Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting
November 09, 2018 07:00 ET
|
Antares Pharma, Inc.
XYOSTED™ AMBULATORY BLOOD PRESURE ABSTRACT HAS BEEN SELECTED FOR POSTER PRESENTATION EWING, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that data...
Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference
November 08, 2018 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2018...
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results
November 06, 2018 07:00 ET
|
Antares Pharma, Inc.
The Company Posts Record Quarterly Revenue Of $17.9 Million EWING, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the Company) today announced operating and financial...
Antares Pharma to Report Third Quarter 2018 Financial and Operating Results
October 30, 2018 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2018 financial results and recent operating progress before the...